Literature DB >> 1704251

The value of anticarcinoembryonic antigen, human milk factor globulin, and antikeratin antibodies in differentiating mesothelioma from lung carcinoma.

V M Joglekar1, D Oliver, M Harris.   

Abstract

Monoclonal anticarcinoembryonic antigen (antiCEA), human milk factor globulin (HMFG2), and antikeratin antibodies were assessed for their value in the differential diagnosis of pleural mesothelioma (53 cases) and carcinoma of the lung (60 cases) in material from necropsies. In 40 of the cases pleural biopsies were also studied in the same manner. AntiCEA was found to be the best discriminating antibody for most types of mesothelioma; HMFG2 was slightly less valuable but a useful additional tool. Antikeratin was the least useful. For both antiCEA and HMFG2 antibodies, however, the proportion of carcinomas staining was smaller than in previous studies and this, combined with the positive staining of some mesotheliomas, reduces the value of the reactions in the individual case. Medical panels adjudicating compensation claims should not use these reactions as the sole criteria in deciding the origin of the tumours in these cases.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1704251      PMCID: PMC1035309          DOI: 10.1136/oem.48.1.34

Source DB:  PubMed          Journal:  Br J Ind Med        ISSN: 0007-1072


  13 in total

1.  Staining properties of melanin and lipofuscin pigments.

Authors:  M Senba
Journal:  Am J Clin Pathol       Date:  1986-10       Impact factor: 2.493

2.  Distinction of mesothelioma from adenocarcinoma. An immunohistochemical approach.

Authors:  H Battifora; M I Kopinski
Journal:  Cancer       Date:  1985-04-15       Impact factor: 6.860

3.  Are keratin proteins a better tumor marker than epithelial membrane antigen? A comparative immunohistochemical study of various paraffin-embedded neoplasms using monoclonal and polyclonal antibodies.

Authors:  G S Pinkus; C L Etheridge; E M O'Connor
Journal:  Am J Clin Pathol       Date:  1986-03       Impact factor: 2.493

4.  Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

Authors:  J L Cordell; B Falini; W N Erber; A K Ghosh; Z Abdulaziz; S MacDonald; K A Pulford; H Stein; D Y Mason
Journal:  J Histochem Cytochem       Date:  1984-02       Impact factor: 2.479

5.  Cerebrospinal fluid concentrations of hypoxanthine, xanthine, uridine and inosine: high concentrations of the ATP metabolite, hypoxanthine, after hypoxia.

Authors:  R A Harkness; R J Lund
Journal:  J Clin Pathol       Date:  1983-01       Impact factor: 3.411

6.  Immunohistological study of malignant diffuse mesotheliomas of the pleura.

Authors:  H Loosli; J Hurlimann
Journal:  Histopathology       Date:  1984-09       Impact factor: 5.087

7.  Use of antibodies to carcinoembryonic antigen and human milk fat globule to distinguish carcinoma, mesothelioma, and reactive mesothelium.

Authors:  R J Marshall; A Herbert; S G Braye; D B Jones
Journal:  J Clin Pathol       Date:  1984-11       Impact factor: 3.411

8.  Immunohistological staining of reactive mesothelium, mesothelioma, and lung carcinoma with a panel of monoclonal antibodies.

Authors:  A K Ghosh; K C Gatter; M S Dunnill; D Y Mason
Journal:  J Clin Pathol       Date:  1987-01       Impact factor: 3.411

9.  The distinction of adenocarcinoma from malignant mesothelioma in cell blocks of effusions: the role of routine mucin histochemistry and immunohistochemical assessment of carcinoembryonic antigen, keratin proteins, epithelial membrane antigen, and milk fat globule-derived antigen.

Authors:  E S Cibas; J M Corson; G S Pinkus
Journal:  Hum Pathol       Date:  1987-01       Impact factor: 3.466

10.  Immunohistochemical staining for keratin and carcinoembryonic antigen in the diagnosis of malignant mesothelioma.

Authors:  J Holden; A Churg
Journal:  Am J Surg Pathol       Date:  1984-04       Impact factor: 6.394

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.